BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17028897)

  • 21. Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
    Sazci A; Ergul E; Aygun C; Akpinar G; Senturk O; Hulagu S
    Cell Biochem Funct; 2008 Apr; 26(3):291-6. PubMed ID: 17563923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between multidrug resistance-1 gene polymorphisms and outcomes of allogeneic HLA-identical stem cell transplantation.
    Kim DH; Park JY; Sohn SK; Lee NY; Suh JS; Lee KB
    Haematologica; 2006 Jun; 91(6):848-51. PubMed ID: 16769591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population.
    Chiusolo P; Reddiconto G; Cimino G; Sica S; Fiorini A; Farina G; Vitale A; Sorà F; Laurenti L; Bartolozzi F; Fazi P; Mandelli F; Leone G
    Haematologica; 2004 Feb; 89(2):139-44. PubMed ID: 15003888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis.
    Soydan E; Topcuoglu P; Dalva K; Arat M
    Bone Marrow Transplant; 2008 Sep; 42(6):429-30. PubMed ID: 18587432
    [No Abstract]   [Full Text] [Related]  

  • 26. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
    Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
    Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 677TT genotype is associated with elevated risk of methotrexate (MTX) toxicity in juvenile idiopathic arthritis: treatment outcome, erythrocyte concentrations of MTX and folates, and MTHFR polymorphisms.
    Tuková J; Chládek J; Hroch M; Nemcová D; Hoza J; Dolezalová P
    J Rheumatol; 2010 Oct; 37(10):2180-6. PubMed ID: 20595278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
    Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
    Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma.
    Chiusolo P; Farina G; Putzulu R; Reddiconto G; Fiorini A; De Stefano V; Rossi E; Palladino M; Leone G; Sica S
    Ann Hematol; 2006 Jul; 85(7):474-7. PubMed ID: 16541270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the methylenetetrahydrofolate reductase A1298C but not the C677T single nucleotide polymorphism with sickle cell disease in Bahrain.
    Al-Absi IK; Al-Subaie AM; Ameen G; Mahdi N; Mohammad AM; Fawaz NA; Almawi WY
    Hemoglobin; 2006; 30(4):449-53. PubMed ID: 16987799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
    Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
    Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
    Piccioli P; Balbi G; Serra M; Morabito A; Lamparelli T; Gobbi M; Laurent S; Dozin B; Bruzzi P; Ferraris AM; Bacigalupo A; Notaro R; Pistillo MP
    Ann Hematol; 2010 Jun; 89(6):613-8. PubMed ID: 20020126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation.
    Middleton PG; Cullup H; Dickinson AM; Norden J; Jackson GH; Taylor PR; Cavet J
    Bone Marrow Transplant; 2002 Aug; 30(4):223-8. PubMed ID: 12203138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation.
    Kalayoglu-Besisik S; Caliskan Y; Sargin D; Gurses N; Ozbek U
    Transplantation; 2003 Dec; 76(12):1775-7. PubMed ID: 14688536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
    Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
    Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Polak M; Lange A
    Bone Marrow Transplant; 2003 Sep; 32(6):617-22. PubMed ID: 12953135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.